Suppr超能文献

β-内酰胺酶的进化

The evolution of beta-lactamases.

作者信息

Bush K

机构信息

Department of Microbial Biochemistry, Astra Research Center Boston, Cambridge, MA 02139, USA.

出版信息

Ciba Found Symp. 1997;207:152-63; discussion 163-6.

PMID:9189640
Abstract

beta-lactamases, the enzymes often associated with resistance to beta-lactam antibiotics, are found in most bacterial species. Although these enzymes protected bacteria from naturally occurring beta-lactams long before the introduction of synthetic antimicrobial agents, the numbers and varieties of beta-lactamases have increased dramatically with the introduction of modern penicillins and cephalosporins. Over the past twenty years it has become apparent that families of beta-lactamases have been selected as the result of antimicrobial usage. Outbreaks of beta-lactam-resistant bacteria can be traced to the introduction of specific classes of beta-lactams or to the introduction of a specific agent. Many of the most serious epidemics can be related to transferable beta-lactamase genes that are harboured on multidrug-resistant plasmids. The separation of beta-lactamases into three major functional groups or four structural classes has been proposed. Stepwise selection of variants within several of these classes has been documented both in the clinical setting and in the laboratory, e.g. the extended-spectrum (TEM and SHV) beta-lactamases and the inhibitor-resistant (TEM) beta-lactamases. Close relationships among the recently described plasmid-mediated 'cephamycinases' and the common chromosomal cephalosporinases have been identified. Carbapenem-hydrolysing metallo-beta-lactamases with broad spectrum hydrolysing activity have become serious concerns as they begin to be described on plasmids. Factors contributing to selection of beta-lactam-resistant strains include decreased outer membrane permeability and increased beta-lactamase production.

摘要

β-内酰胺酶是一种常与对β-内酰胺类抗生素耐药性相关的酶,存在于大多数细菌种类中。尽管早在合成抗菌剂出现之前,这些酶就保护细菌免受天然存在的β-内酰胺的影响,但随着现代青霉素和头孢菌素的引入,β-内酰胺酶的数量和种类急剧增加。在过去二十年中,很明显β-内酰胺酶家族是抗菌药物使用的结果而被选择出来的。耐β-内酰胺细菌的暴发可追溯到特定类别的β-内酰胺的引入或特定药物的引入。许多最严重的流行与携带在多重耐药质粒上的可转移β-内酰胺酶基因有关。有人提出将β-内酰胺酶分为三个主要功能组或四个结构类别。在临床环境和实验室中都记录了这些类别中几种变体的逐步选择,例如超广谱(TEM和SHV)β-内酰胺酶和耐抑制剂(TEM)β-内酰胺酶。最近描述的质粒介导的“头孢菌素酶”与常见的染色体头孢菌素酶之间已确定存在密切关系。随着携带广谱水解活性的碳青霉烯水解金属β-内酰胺酶开始在质粒上被描述,它们已成为严重问题。导致耐β-内酰胺菌株选择的因素包括外膜通透性降低和β-内酰胺酶产生增加。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验